Screener
Charles River Laboratories CRL Adjustment of redeemable noncontrolling interests to redemption value
Adjustment of redeemable noncontrolling interests to redemption value at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:TemporaryEquityAccretionToRedemptionValueNet.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Redeemable Noncontrolling Interests | Common stock / Shares | Common stock / Amount | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock / Shares | Treasury Stock / Amount | Total Equity Attributableto Common Shareholders | Noncontrolling Interest | Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 3,492 | — | — | — | 474,624 | — | — | — | 474,624 | 2,254 | 476,878 |
| Other comprehensive income (loss) | (1,200) | — | — | — | — | 65,630 | — | — | 65,630 | — | 65,630 |
| Dividends declared to noncontrolling interest | (2,378) | — | — | — | — | — | — | — | — | (1,645) | (1,645) |
| Adjustment of redeemable noncontrolling interests to redemption value | (5,694) | — | — | 5,694 | — | — | — | — | 5,694 | — | 5,694 |
| Purchase of remaining equity interest of Vital River redeemable noncontrolling interest | (24,148) | — | — | — | — | — | — | — | — | — | — |
| Gain on purchase of remaining equity interest of Vital River redeemable noncontrolling interest | (1,151) | — | — | 1,151 | — | — | — | — | 1,151 | — | 1,151 |
| Acquisition of redeemable noncontrolling interest | 45,374 | — | — | — | — | — | — | — | — | — | — |
| Issuance of stock under employee compensation plans | — | 499 | 5 | 25,592 | — | — | — | — | 25,597 | — | 25,597 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's adjustment of redeemable noncontrolling interests to redemption value?
- Charles River Laboratories (CRL) reported adjustment of redeemable noncontrolling interests to redemption value of -$1.42M in Q4 2023.
- What does adjustment of redeemable noncontrolling interests to redemption value mean?
- The periodic adjustment of redeemable noncontrolling interests to their estimated redemption value. This reflects changes in the fair value or contractual obligation to purchase minority shares in the future.
Ask your AI about Charles River Laboratories's adjustment of redeemable noncontrolling interests to redemption value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude